2025 annual financial data
Addex Therapeutics 2025 Net margin
Direct answer
Net margin was -22,448.44%.
Operating income was -2,814,598 CHF and net income was -6,728,246 CHF.
Operating cash flow was -2,075,821 CHF.
Get free Addex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,972 CHF
- Operating income
- -2,814,598 CHF
- Net income
- -6,728,246 CHF
- Operating cash flow
- -2,075,821 CHF